INZY
Inozyme Pharma Inc
Price:  
4.00 
USD
Volume:  
1,457,159.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

INZY Relative Valuation

-631.0%
Upside

As of 2025-07-01, the Relative Valuation of Inozyme Pharma Inc (INZY) is (21.24) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.00 USD, the upside of Inozyme Pharma Inc based on Relative Valuation is -631.0%.

The range of the Relative Valuation is (16.36) - (29.22) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 8.4x - 17.7x 12.6x
Forward P/E multiples 9.9x - 20.1x 13.1x
Fair Price (16.36) - (29.22) (21.24)
Upside -509.1% - -830.6% -631.0%
4.00 USD
Stock Price
(21.24) USD
Fair Price

INZY Relative Valuation - Historical P/E Data

Date P/E
2025-06-27 -2.41
2025-06-26 -2.42
2025-06-25 -2.41
2025-06-24 -2.41
2025-06-23 -2.41
2025-06-20 -2.41
2025-06-18 -2.41
2025-06-17 -2.41
2025-06-16 -2.40
2025-06-13 -2.41
2025-06-12 -2.41
2025-06-11 -2.40
2025-06-10 -2.41
2025-06-09 -2.41
2025-06-06 -2.41
2025-06-05 -2.41
2025-06-04 -2.41
2025-06-03 -2.41
2025-06-02 -2.40
2025-05-30 -2.40
2025-05-29 -2.39
2025-05-28 -2.39
2025-05-27 -2.39
2025-05-23 -2.40
2025-05-22 -2.40
2025-05-21 -2.39
2025-05-20 -2.39
2025-05-19 -2.41
2025-05-16 -2.39
2025-05-15 -0.86
2025-05-14 -0.82
2025-05-13 -0.66
2025-05-12 -0.71
2025-05-09 -0.70
2025-05-08 -0.75
2025-05-07 -0.80
2025-05-06 -0.76
2025-05-05 -0.90
2025-05-02 -0.98
2025-05-01 -0.73
2025-04-30 -0.70
2025-04-29 -0.64
2025-04-28 -0.58
2025-04-25 -0.60
2025-04-24 -0.58
2025-04-23 -0.59
2025-04-22 -0.62
2025-04-21 -0.59
2025-04-17 -0.56
2025-04-16 -0.58